Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis

Aim: To evaluate the efficacy of switching from bevacizumab to ranibizumab or aflibercept in eyes with diabetic macular edema (DME) unresponsive to bevacizumab. Methods: Single-center retrospective comparative study of patients with DME unresponsive to intravitreal bevacizumab that was switched to r...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pessoa, Bernardete (author)
Outros Autores: Malheiro, Luísa (author), Carneiro, Inês (author), Monteiro, Sílvia (author), Coelho, João (author), Coelho, Constança (author), Figueira, João (author), Meireles, Angelina (author), Beirão, João Nuno Melo (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
aflibercept
bevacizumab
diabetic macular edema
ranibizumab, refractory
Texto completo:http://hdl.handle.net/10316/103835
País:Portugal
Oai:oai:estudogeral.sib.uc.pt:10316/103835

Texto Completo

http://hdl.handle.net/10316/103835

Registos relacionados